X4 Pharmaceuticals, Inc (XFOR) (CIK 0001501697) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001501697-25-000019
- Form
- CORRESP
- Filer
- X4 Pharmaceuticals, Inc (XFOR) (CIK 0001501697)
- CIK
- 0001501697
- Ticker
- XFOR
- Filed
- 2025-09-15
- SIC industry
- 2836
- HQ
- Boston, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1501697/000150169725000019/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer